Direct cancer tissue proteomics: A method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues

Oncogene

Volumn 26, Issue 1, 2007, Pages 65-76

  Hwang, S I ^a   Thumar, J ^a   Lundgren, D H ^a   Rezaul, K ^a   Mayya, V ^a   Wu, L ^a   Eng, J ^b   Wright, M E ^c   Han, D K ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Direct tissue proteomics (DTP); Formalin fixed paraffin embedded tissues; LC MS MS; Prostate cancer; Prostate specific antigen (PSA); Wnt

Indexed keywords

BIOLOGICAL MARKER; FORMALDEHYDE; PARAFFIN; PROSTATE SPECIFIC ANTIGEN; WNT3 PROTEIN;

ARTICLE; BIOINFORMATICS; CANCER CELL; CANCER DIAGNOSIS; CANCER TISSUE; CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIRECT TISSUE PROTEOMICS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETER; MULTIPLE CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; UPREGULATION;

AMINO ACID SEQUENCE; COMPUTATIONAL BIOLOGY; FORMALDEHYDE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; PROSTATIC NEOPLASMS; PROTEOMICS; TUMOR MARKERS, BIOLOGICAL;

EID: 33846109371     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209755     Document Type: Article

References (47)

1. Cantin GT, Yates III JR. (2004). J Chromatogr A 1053: 7-14.
2. Coombs GS, Bergstrom RC, Pellequer JL, Baker SI, Navre M, Smith MM et al. (1998). Chem Biol 5: 475-488.
3. Cox C, Bignell G, Greenman C, Stabenau A, Warren W, Stephens P et al. (2005). Proc Natl Acad Sci USA 102: 4542-4547.
4. Cronauer MV, Schulz WA, Ackermann R, Burchardt M. (2005). Int J Oncol 26: 1033-1040.
5. DePinho RA, Polyak K. (2004). Nat Genet 36: 932-934.
6. Eng JK, McCormack AL, Yates III JR. (1994). J Am Soc Mass Spectrom 5: 976-989.
7. Ford TF, Butcher DN, Masters JR, Parkinson MC. (1985). Br J Urol 57: 50-55.
8. George DJ. (2002). Urology 60: 115-121; discussion 122.
9. Gerber SA, Rush J, Stemman O, Kirschner MW, Gygi SP. (2003). Proc Natl Acad Sci USA 100: 6940-6945.
10. Gleason DF. (1988). NCI Monogr 7: 15-18.
11. Gleason DF. (1992). Hum Pathol 23: 273-279.
12. Griffin TJ, Lock CM, Li XJ, Patel A, Chervetsova I, Lee H et al. (2003). Anal Chem 75: 867-874.
13. Gupta A, Roehrborn C, Aragaki C. (2004). J Urol 171: 2384-2385 (author reply 2385).
14. Gygi SP, Rochon Y, Franza BR, Aebersold R. (1999). Mol Cell Biol 19: 1720-1730.
15. Han DK, Eng J, Zhou H, Aebersold R. (2001). Nat Biotechnol 19: 946-951.
16. Hood BL, Darfler MM, Guiel TG, Furusato B, Lucas DA, Ringeisen BR et al. (2005). Mol Cell Proteomics 4: 1741-1753.
17. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. (2002). Anal Chem 74: 5383-5392.
18. Lundgren DH, Eng J, Wright ME, Han DK. (2003). Mol Cell Proteomics 2: 1164-1176.
19. Mayya V, Rezaul K, Cong YS, Han D. (2005). Mol Cell Proteomics 4: 214-223.
20. Meyerson M, Carbone D. (2005). J Clin Oncol 23: 3219-3226.
21. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S et al. (2004). J Biol Chem 279: 1310-1322.
22. Nelson PS, Han D, Rochon Y, Corthals GL, Lin B, Monson A et al. (2000). Electrophoresis 21: 1823-1831.
23. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. (2003). Anal Chem 75: 4646-4658.
24. Parnes HL, Thompson IM, Ford LG. (2005). J Clin Oncol 23: 368-377.
25. Patterson SD. (2004). Arthritis Rheum 50: 3741-3744.
26. Peng J, Elias JE, Thoreen CC, Licklider LJ, Gygi SP. (2003). J Proteome Res 2: 43-50.
27. Petricoin EF, Zoon KC, Kohn EC, Barrett JC, Liotta LA. (2002). Nat Rev Drug Discov 1: 683-695.
28. Posadas EM, Simpkins F, Liotta LA, MacDonald C, Kohn EC. (2005). Ann Oncol 16: 16-22.
29. Raben D, Helfrich B. (2004). Clin Lung Cancer 6: 48-57.
30. Rezaul K, Wu L, Mayya V, Hwang SI, Han D. (2005). Mol Cell Proteomics 4: 169-181.
31. Sawyers CL. (2002). Curr Opin Genet Dev 12: 111-115.
32. Sharpless NE, DePinho RA. (2005). Nature 436: 636-637.
33. Smith RA, Cokkinides V, Eyre HJ. (2005). CA Cancer J Clin 55: 31-44; quiz 55-56.
34. Stephens P, Edkins S, Davies H, Greenman C, Cox C, Hunter C et al. (2005). Nat Genet 37: 590-592.
35. Sweat GT. (2005). Postgrad Med 117: 45-50.
36. Tanneberger S. (1977). Arch Geschwulstforsch 47: 755-765.
37. Tarro G, Perna A, Esposito C. (2005). J Cell Physiol 203: 1-5.
38. Tonon G, Wong KK, Maulik G, Brennan C, Feng B, Zhang Y et al. (2005). Proc Natl Acad Sci USA 102: 9625-9630.
39. Velasco AM, Gillis KA, Li Y, Brown EL, Sadler TM, Achilleos M et al. (2004). Endocrinology 145: 3913-3924.
40. Verras M, Brown J, Li X, Nusse R, Sun Z. (2004). Cancer Res 64: 8860-8866.
41. Wardwell NR, Massion PP. (2005). Semin Oncol 32: 259-268.
42. Wilson JF. (2004). Ann Intern Med 140: 317-319.
43. Wolters DA, Washburn MP, Yates III JR. (2001). Anal Chem 73: 5683-5690.
44. Wright ME, Eng J, Sherman J, Hockenbery DM, Nelson PS, Galitski T et al. (2003). Genome Biol 5: R4.
45. Wright ME, Han DK, Aebersold R. (2005). Mol Cell Proteomics 4: 545-554.
46. Zangar RC, Varnum SM, Covington CY, Smith RD. (2004). Dis Markers 20: 135-148.
47. Zhu H, Mazor M, Kawano Y, Walker MM, Leung HY, Armstrong K et al. (2004). Cancer Res 64: 7918-7926.